Mono Pharmacare Limited Appoints R K Mergu & Co as Statutory Auditor for FY 2025-26
The Board of Directors of Mono Pharmacare Limited appointed M/s R K Mergu & Co, Chartered Accountants, as the Statutory Auditor of the company. The decision was made during a board meeting held on June 3, 2026.The appointment involves filling a casual vacancy that arose following the resignation of Kumbhat & Co: LLP, Chartered Accountant. M/s R K Mergu & Co has been appointed to conduct the audit for the Financial Year 2025-26 and will hold office until the conclusion of the next Annual General Meeting.
The appointment details and background information regarding the selected firm are as follows:
| Particulars | Detail |
|---|---|
| Auditor Name | M/s R.K. Mergu & Co (FRN NO: 136876W) |
| Reason for Appointment | Filling a casual vacancy due to the resignation of Kumbhat & Co: LLP, Chartered Accountant. |
| Financial Year Covered | Financial Year 2025-26 |
| Appointment Date | June 3, 2026 |
M/s R.K. Mergu & Co is an ICAl registered firm established by a Chartered Accountant with a vision to provide comprehensive solutions across all areas of finance and accounting. The firm operates on a strong foundation of quality, employing a business focused and result oriented approach to client service. Disclosure of relationships between directors regarding this appointment was noted as Not Applicable.
MONOPHARMA Stock Price Movement
Mono Pharmacare Limited shares slipped today after closing at ₹11.40, down 5.00% from the previous close. The stock traded on a volume of 4,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.